Norway - Stavanger: Various medicinal products

Watch this tender

Summary

Please scroll down for full details
Threshold: 
OJEU
Main activities: 
General public services
Type: 
Additional information
Type of contract: 
SUPPLIES
Award criteria: 
The most economic tender
Published: 
Saturday, August 26, 2017
Tender ID: 
2017/S 163-337330

Corrigendum

Notice for changes or additional information

Supplies

(Supplement to the Official Journal of the European Union, 2017/S 128-262782)

Section I: Contracting authority/entity

I.1)

Name and addresses
Stavanger Kommune
964965226
Kongsgårdbakken 3
Stavanger
4005
Norway
Contact person: Emilia Tufto
E-mail: emilia.tufto@stavanger.kommune.no
NUTS code: NO043

Internet address(es):

Main address: http://permalink.mercell.com/70387198.aspx

Address of the buyer profile: https://www.stavanger.kommune.no

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title:

Delivery of medicines for stores and medicines packed in multi-dose, single dose, and multiple dose.

Reference number: 17/04573

II.1.2)

Main CPV code
33690000

II.1.3)

Type of contract
Supplies

II.1.4)

Short description:

The contracting authority invites tenderers to an open tender contest for a contract for the procurement of medicines and packing multi-dose, single dose and multiple doses. A contract will be signed with one (1) tenderer.

Section VI: Complementary information

VI.5)

Date of dispatch of this notice:
24/08/2017

VI.6)

Original notice reference
Notice number in the OJ S: 2017/S 128-262782

Section VII: Changes

VII.1)

Information to be changed or added

VII.1.2)

Text to be corrected in the original notice
Section number: IV.2.2)
Place of text to be modified: Time limit for receipt of tenders or requests to participate:
Instead of:
Date: 25/08/2017
Local time: 12:00
Read:
Date: 01/09/2017
Local time: 12:00
Section number: IV.2.7)
Place of text to be modified: Conditions for opening of tenders:
Instead of:
Date: 25/08/2017
Local time: 12:00
Read:
Date: 01/09/2017
Local time: 12:00

VII.2)

Other additional information: